Comprehensive therapy and genetic counseling for one patient with <italic style="font-style: italic">SMARCA</italic>4 germline-mutated small cell carcinoma, the ovary of hypercalcemic type

Yi GAO; Mingyi KANG; Hui WANG; Jing XU; Yue SHI; Xiang TAO; Fenghua MA; Haowen TAN; Yu KANG; Congjian XU

doi:10.19401/j.cnki.1007-3639.2022.11.010

您当前的位置：

首页 >

文章列表页 >

Comprehensive therapy and genetic counseling for one patient with SMARCA4 germline-mutated small cell carcinoma, the ovary of hypercalcemic type

Case Report | 更新时间：2025-12-31

- Comprehensive therapy and genetic counseling for one patient with SMARCA4 germline-mutated small cell carcinoma, the ovary of hypercalcemic type
- China Oncology Vol. 32, Issue 11, Pages: 1115-1120(2022)
- 作者机构：
  
  1. 复旦大学附属妇产科医院妇科，上海 200011
  2. 上海市女性生殖内分泌相关疾病重点实验室，上海 200011
  3. 复旦大学附属妇产科医院护理部，上海 200011
  4. 复旦大学附属妇产科医院病理科，上海 200011
  5. 复旦大学附属妇产科医院放射科，上海 200011
  6. 江西合因教育科技有限公司，江西赣州 342604
  7. 复旦大学上海医学院妇产科学系，上海，200032
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2022.11.010
  CLC： R737.31
- Received：08 June 2022，
  
  Revised：2022-11-15，
  
  Published：30 November 2022
- 稿件说明：
移动端阅览
Yi GAO, Mingyi KANG, Hui WANG, et al. Comprehensive therapy and genetic counseling for one patient with SMARCA4 germline-mutated small cell carcinoma, the ovary of hypercalcemic type[J]. China Oncology, 2022, 32(11): 1115-1120.
DOI：

Yi GAO, Mingyi KANG, Hui WANG, et al. Comprehensive therapy and genetic counseling for one patient with SMARCA4 germline-mutated small cell carcinoma, the ovary of hypercalcemic type[J]. China Oncology, 2022, 32(11): 1115-1120. DOI： 10.19401/j.cnki.1007-3639.2022.11.010.

摘要

Abstract

关键词

Keywords

references

PODWIKA S E , JENKINS T M , KHOKHAR J K , et al. Optimal age for genetic cancer predisposition testing in hereditary SMARCA 4 ovarian cancer families: how young is too young? [J ] . Gynecol Oncol Rep , 2020 , 32 : 100569 .

LEE E K , ESSELEN K M , KOLIN D L , et al. Combined CDK4/6 and PD-1 inhibition in refractory SMARCA 4-deficient small-cell carcinoma of the ovary, hypercalcemic type [J ] . JCO Precis Oncol , 2020 , 4 : 736 - 742 .

CONNOR Y D , MIAO D A , LIN D I , et al. Germline mutations of SMARCA 4 in small cell carcinoma of the ovary, hypercalcemic type and in SMARCA 4-deficient undifferentiated uterine sarcoma: clinical features of a single family and comparison of large cohorts [J ] . Gynecol Oncol , 2020 , 157 ( 1 ): 106 - 114 . DOI: 10.1016/j.ygyno.2019.10.031 http://doi.org/10.1016/j.ygyno.2019.10.031 https://linkinghub.elsevier.com/retrieve/pii/S009082581931618X https://linkinghub.elsevier.com/retrieve/pii/S009082581931618X

HUGHES I A , HOUK C , AHMED S F , et al. Consensus statement on management of intersex disorders [J ] . J Pediatr Urol , 2006 , 2 ( 3 ): 148 - 162 . DOI: 10.1016/j.jpurol.2006.03.004 http://doi.org/10.1016/j.jpurol.2006.03.004

FOULKES W D , KAMIHARA J , EVANS D G R , et al. Cancer surveillance in gorlin syndrome and rhabdoid tumor predisposition syndrome [J ] . Clin Cancer Res , 2017 , 23 ( 12 ): e62 -e67. DOI: 10.1158/1078-0432.CCR-17-0595 http://doi.org/10.1158/1078-0432.CCR-17-0595 https://aacrjournals.org/clincancerres/article/23/12/e62/80076/Cancer-Surveillance-in-Gorlin-Syndrome-and https://aacrjournals.org/clincancerres/article/23/12/e62/80076/Cancer-Surveillance-in-Gorlin-Syndrome-and

PEJOVIC T , MCCLUGGAGE W G , KRIEG A J , et al. The dilemma of early preventive oophorectomy in familial small cell carcinoma of the ovary of hypercalcemic type [J ] . Gynecol Oncol Rep , 2019 , 28 : 47 - 49 .

YOUNG R H , OLIVA E , SCULLY R E . Small cell carcinoma of the ovary, hypercalcemic type. A clinicopathological analysis of 150 cases [J ] . Am J Surg Pathol , 1994 , 18 ( 11 ): 1102 - 1116 .

CALLEGARO-FILHO D , GERSHENSON D M , NICK A M , et al. Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): a review of 47 cases [J ] . Gynecol Oncol , 2016 , 140 ( 1 ): 53 - 57 . DOI: 10.1016/j.ygyno.2015.11.004 http://doi.org/10.1016/j.ygyno.2015.11.004 https://linkinghub.elsevier.com/retrieve/pii/S0090825815301761 https://linkinghub.elsevier.com/retrieve/pii/S0090825815301761

WITKOWSKI L , GOUDIE C , RAMOS P , et al. The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type [J ] . Gynecol Oncol , 2016 , 141 ( 3 ): 454 - 460 . DOI: S0090-8258(16)30071-3 http://doi.org/S0090-8258(16)30071-3

JAMY O , YAGHMOUR G , HARE F , et al. Population-based analysis of the clinical features of primary small cell carcinoma of the ovary [J ] . Anticancer Res , 2015 , 35 ( 5 ): 3091 - 3095 .

ESTEL R , HACKETHAL A , KALDER M , et al. Small cell carcinoma of the ovary of the hypercalcaemic type: an analysis of clinical and prognostic aspects of a rare disease on the basis of cases published in the literature [J ] . Arch Gynecol Obstet , 2011 , 284 ( 5 ): 1277 - 1282 . DO I: 10.1007/s00404-011-1846-5 http://doi.org/10.1007/s00404-011-1846-5

RAY-COQUARD I , MORICE P , LORUSSO D , et al. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J ] . Ann Oncol , 2018 , 29 ( Suppl 4 ): iv1 -iv18. DOI: 10.1093/annonc/mdy001 http://doi.org/10.1093/annonc/mdy001 https://linkinghub.elsevier.com/retrieve/pii/S0923753419316898 https://linkinghub.elsevier.com/retrieve/pii/S0923753419316898

WANG Y M , CHEN S Y , KARNEZIS A N , et al. The histone methyltransferase EZH2 is a therapeutic target in small cell carcinoma of the ovary, hypercalcaemic type [J ] . J Pathol , 2017 , 242 ( 3 ): 371 - 383 . DOI: 10.1002/path.4912 http://doi.org/10.1002/path.4912 https://onlinelibrary.wiley.com/doi/10.1002/path.4912 https://onlinelibrary.wiley.com/doi/10.1002/path.4912

WANG Y M , CHEN S Y , COLBORNE S , et al. Histone deacetylase inhibitors synergize with catalytic inhibitors of EZH2 to exhibit antitumor activity in small cell carcinoma of the ovary, hypercalcemic type [J ] . Mol Cancer Ther , 2018 , 17 ( 12 ): 2767 - 2779 . DOI: 10.1158/1535-7163.MCT-18-0348 http://doi.org/10.1158/1535-7163.MCT-18-0348

SOLDI R , GHOSH HALDER T , WESTON A , et al. The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer [J ] . PLoS One , 2020 , 15 ( 7 ): e0235705 . DOI: 10.1371/journal.pone.0235705 http://doi.org/10.1371/journal.pone.0235705 https://dx.plos.org/10.1371/journal.pone.0235705 https://dx.plos.org/10.1371/journal.pone.0235705

LANG J D , HENDRICKS W P D , ORLANDO K A , et al. Ponatinib shows potent antitumor activity in small cell carcinoma of the ovary hypercalcemic type (SCCOHT) through multikinase inhibition [J ] . Clin Cancer Res , 2018 , 24 ( 8 ): 1932 - 1943 . DOI: 10.1158/1078-0432.CCR-17-1928 http://doi.org/10.1158/1078-0432.CCR-17-1928

XUE Y B , MEEHAN B , MACDONALD E , et al. CDK4/6 inhibitors target SMARCA 4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary [J ] . Nat Commun , 2019 , 10 ( 1 ): 558 . DOI: 10.1038/s41467-018-06958-9 http://doi.org/10.1038/s41467-018-06958-9 https://doi.org/10.1038/s41467-018-06958-9 https://doi.org/10.1038/s41467-018-06958-9

JELINIC P , RICCA J , VAN OUDENHOVE E , et al. Immune-active microenvironment in small cell carcinoma of the ovary, hypercalcemic type: rationale for immune checkpoint blockade [J ] . J Natl Cancer Inst , 2018 , 110 ( 7 ): 787 - 790 . DOI: 10.1093/jnci/djx277 http://doi.org/10.1093/jnci/djx277

TISCHKOWITZ M , HUANG S D , BANERJEE S , et al. Small-cell carcinoma of the ovary, hypercalcemic type-genetics, new treatment targets, and current management guidelines [J ] . Clin Cancer Res , 2020 , 26 ( 15 ): 3908 - 3917 . DOI: 10.1158/1078-0432.CCR-19-3797 http://doi.org/10.1158/1078-0432.CCR-19-3797

ZHANG F F , WANG W J , LONG Y , et al. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response [J ] . Cancer Commun (Lond) , 2018 , 38 ( 1 ): 60 .

BERCHUCK A , WITKOWSKI L , HASSELBLATT M , et al. Prophylactic oophorectomy for hereditary small cell carcinoma of the ovary, hypercalcemic type [J ] . Gynecol Oncol Rep , 2015 , 12 : 20 - 22 .

Views

2224

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Expert consensus on genetic counseling in gynecological oncology (2023 edition)

Single-cell RNA sequencing reveals tissue architecture in small cell carcinoma of the ovary, hypercalcemic type

Related Author

Mingyi KANG

Yi GAO

Jing XU

Yu KANG

Congjian XU

Related Institution

Gynecologic Oncology Genetic Counseling Collaboration Group, Chinese Tertiary Obstetrics and Gynecology Hospital/Materning and Child Healthcare Hospital Alliance; Integrated Chinese and Western Endometrial Cancer Professional Committee, Chinese Anti-Cancer Association

Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University

Department of Obstetrics and Gynecology of Shanghai Medical College, Fudan University

AI问答

⁰

Comprehensive therapy and genetic counseling for one patient with SMARCA4 germline-mutated small cell carcinoma, the ovary of hypercalcemic type

DOI：10.19401/j.cnki.1007-3639.2022.11.010

摘要

Abstract

关键词

Keywords

references